$PBIO the Second Straight Year, Over 20 Journal Articles Highlight the Benefits of PBI's Patented PCT Platform in Such Critical Areas of Research as Cancer, Food Safety, and Proteomics
South Easton, Massachusetts--(Newsfile Corp. - January 9, 2020) - Pressure BioSciences, Inc. a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the life sciences and other industries, today announced that in 2019 - for the second straight year - over 20 scientific papers highlighting the advantages of PBI's patented pressure cycling technology ("PCT"
platform were published worldwide. Authored by independent scientists from academia, government, and industry, these publications highlighted the powerful and enabling benefits of the PCT Platform in such critical areas as cancer research, food safety, and proteomics. Number of Published Scientific Papers Citing the Advantages of Pressure BioSciences' PCT Platform Remained Strong in 2019 https://finance.yahoo.com/news/number-publish...00983.html